The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 412.20
Bid: 412.80
Ask: 412.90
Change: 1.70 (0.41%)
Spread: 0.10 (0.024%)
Open: 412.30
High: 416.40
Low: 410.50
Prev. Close: 410.50
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

11 May 2023 09:17

RNS Number : 1089Z
Rentokil Initial PLC
11 May 2023
 

RESULTS OF ANNUAL GENERAL MEETING 2023 ('AGM')

 

At the AGM of Rentokil Initial plc duly convened and held at, and broadcast from, the Company's offices at Compass House, Manor Royal, Crawley, West Sussex, RH10 9PY on 10 May 2023 at 15:00, each resolution as set out in the notice of meeting dated 4 April 2023 was passed on a poll. The results are set out below and will be placed on the Company website at www.rentokil-initial.com/investors.

 

RESOLUTION

VOTES FOR1

%

VOTES AGAINST

%

TOTAL VOTES

% of ISC VOTED

VOTES WITHHELD2

1

To receive the audited financial statements and the directors' and auditors' report thereon

2,107,213,031

99.88

2,586,165

0.12

2,109,799,196

83.72%

7,677,619

2

To approve the Directors' Remuneration Report

2,083,701,500

98.71

27,209,596

1.29

2,110,911,096

83.76%

6,565,719

3

To approve the rules of the Restricted Share Plan

2,095,739,160

99.06

19,924,531

0.94

2,115,663,691

83.95%

1,813,124

4

To approve the rules of the Deferred Bonus Plan

2,108,763,912

99.67

6,895,776

0.33

2,115,659,688

83.95%

1,817,127

5

To declare a final dividend

2,102,805,475

99.38

13,017,019

0.62

2,115,822,494

83.96%

1,654,321

6

To elect David Frear as a Director

2,109,000,527

99.68

6,802,703

0.32

2,115,803,230

83.96%

1,673,585

7

To elect Sally Johnson as a Director

2,114,190,611

99.92

1,615,245

0.08

2,115,805,856

83.96%

1,670,959

8

To re-elect Stuart Ingall-Tombs as a director

2,090,295,400

98.79

25,506,701

1.21

2,115,802,101

83.96%

1,674,714

9

To re-elect Sarosh Mistry as a director

2,088,769,856

98.72

27,038,112

1.28

2,115,807,968

83.96%

1,668,847

10

To re-elect John Pettigrew as a director

2,089,181,928

98.74

26,624,687

1.26

2,115,806,615

83.96%

1,670,200

11

To re-elect Andy Ransom as a director

2,105,134,787

99.50

10,676,636

0.50

2,115,811,423

83.96%

1,665,392

12

To re-elect Richard Solomons as a director

2,030,910,338

96.27

78,741,433

3.73

2,109,651,771

83.72%

7,825,044

13

To re-elect Cathy Turner as a director

2,089,232,012

98.74

26,583,619

1.26

2,115,815,631

83.96%

1,661,184

14

To re-elect Linda Yueh as a director

2,035,022,912

96.18

80,790,185

3.82

2,115,813,097

83.96%

1,663,718

15

To re-appoint PricewaterhouseCoopers LLP as auditor

2,106,120,703

99.54

9,664,128

0.46

2,115,784,831

83.96%

1,691,984

16

To authorise the directors to agree the auditors' remuneration

2,106,066,853

99.54

9,725,107

0.46

2,115,791,960

83.96%

1,684,855

17

To authorise the making of political donations

2,109,051,481

99.68

6,672,307

0.32

2,115,723,788

83.96%

1,753,027

18

To authorise the directors to allot shares

2,006,904,476

94.86

108,717,211

5.14

2,115,621,687

83.95%

1,855,128

19

To disapply statutory pre-emption rights

1,847,000,296

87.32

268,090,572

12.68

2,115,090,868

83.93%

2,385,947

20

To disapply statutory pre-emption rights for acquisitions and specified capital investments

1,799,119,333

85.23

311,707,895

14.77

2,110,827,228

83.76%

6,649,587

21

To authorise the Directors to make market purchases of the Company's own shares

2,086,290,541

98.64

28,770,845

1.36

2,115,061,386

83.93%

2,415,429

22

To authorise the calling of a general meeting (other than an annual general meeting) on 14 days' clear notice

2,023,577,868

95.64

92,213,241

4.36

2,115,791,109

83.96%

1,685,706

23

To adopt the Articles of Association of the Company produced to the meeting

2,108,374,674

99.88

2,603,077

0.12

2,110,977,751

83.77%

6,499,064

 

1. Votes For include those votes giving the Chairman discretion.

2. A vote withheld is not a vote in law and is not counted in the calculation of proportion of votes cast for or against a resolution.

 

The number of ordinary shares in issue at close of business on 9 May 2023 was 2,520,039,885 ordinary shares of 1p each. Resolutions 19 to 23 were proposed as special resolutions. A copy of the resolutions can be found in the Notice of Meeting available at www.rentokil-initial.com/agm.

 

A copy of the resolutions passed concerning special business has been submitted and will shortly be available for inspection at the National Storage Mechanism located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Enquiries:

 

Company Secretary:

Catherine Stead

Rentokil Initial plc

+44 (0)7826 533700

Media:

Malcolm Padley

Rentokil Initial plc 

+44 (0)7788 978199

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFMSAFEDSEFI
Date   Source Headline
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.